250 related articles for article (PubMed ID: 6290807)
1. Malignant hyperthermia.
Nissen RL; Yonkers AJ
Laryngoscope; 1982 Oct; 92(10 Pt 1):1183-6. PubMed ID: 6290807
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia: current trends in treatment.
Newson AJ
N Z Med J; 1973 Feb; 77(489):81-3. PubMed ID: 4512499
[No Abstract] [Full Text] [Related]
3. Malignant hyperthermia: current perspectives.
Felice-Johnson J; Sudds T; Bennett G
Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia.
Faust DK
Alaska Med; 1985; 27(1):1-2. PubMed ID: 2988361
[No Abstract] [Full Text] [Related]
5. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
[No Abstract] [Full Text] [Related]
6. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S
Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881
[TBL] [Abstract][Full Text] [Related]
7. [Experimental malignant hyperthermia].
Mayzner-Zawadzka E
Pol Tyg Lek; 1980 Dec; 35(52):2073-76. PubMed ID: 7027208
[No Abstract] [Full Text] [Related]
8. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperpyrexia.
Stephen CR
Annu Rev Med; 1977; 28():153-7. PubMed ID: 324354
[TBL] [Abstract][Full Text] [Related]
10. [Malignant hyperthermia].
Bouhajja B; Haddad F; Ben Ammar MS
Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of malignant hyperthermia.
Ording H
Ann Fr Anesth Reanim; 1989; 8(5):411-6. PubMed ID: 2697155
[TBL] [Abstract][Full Text] [Related]
12. [Malignant hyperthermia].
Glahn KP
Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
[TBL] [Abstract][Full Text] [Related]
13. [A case of malignant hyperthermia without hyperthermia].
Muiños PA; Ortells MA; Sánchez G; Carrasco MS
Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
[No Abstract] [Full Text] [Related]
14. [Sodium dantrolene].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
[No Abstract] [Full Text] [Related]
15. Malignant hyperthermia following intravenous iodinated contrast media. Report of a fatal case.
Mozley PD
Diagn Gynecol Obstet; 1981; 3(1):81-6. PubMed ID: 7011755
[TBL] [Abstract][Full Text] [Related]
16. [Malignant hyperthermia].
Chastonay P; Bracco D; Freymond D; Ravussin P
Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
[TBL] [Abstract][Full Text] [Related]
17. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia.
Schwartz HC; Gracia RM
J Oral Surg; 1975 Jan; 33(1):57-60. PubMed ID: 1053652
[TBL] [Abstract][Full Text] [Related]
19. Current concepts of malignant hyperthermia.
Jafek BW; Solomons CC; Masson NC; Mahowald MC; Gumprecht TF
Otolaryngol Head Neck Surg; 1981; 89(6):891-7. PubMed ID: 6801585
[TBL] [Abstract][Full Text] [Related]
20. [Malignant hyperthermia--clinical aspects and treatment of life-endangering complications of anesthesia].
Purschke R; Zindler M
Chirurg; 1974 Oct; 45(10):472-6. PubMed ID: 4462988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
